Does coffee drinking protect cirrhotic patients against hepatocellular carcinoma?

被引:0
|
作者
Stucker, Isabelle
N'Kontchou, Gisele
Loriot, Marie-Anne
Cenee, Sylvie
Gelu-Simeon, Moana
Degos, Francoise
Beaune, Philippe
Laurent-Puig, Pierre
Trinchet, Jean-Claude
Pelletier, Gilles
机构
[1] INSERM, U170, Villejuif, France
[2] Hop Jean Verdier, Bondy, France
[3] INSERM, U775, Paris, France
[4] Hop Bicetre, Le Kremlin Bicetre, France
[5] Hop Beaujon, Clichy, France
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
840
引用
收藏
页码:501A / 501A
页数:1
相关论文
共 50 条
  • [41] Etiology and clinical presentation of hepatocellular carcinoma that develops in cirrhotic and non-cirrhotic patients
    Nitoiu, D
    Buligescu, L
    Micu, L
    Buzatu, E
    JOURNAL OF HEPATOLOGY, 2000, 32 : 170 - 170
  • [42] Hepatocellular adenoma as a risk factor for hepatocellular carcinoma in a non-cirrhotic liver: a plea against
    Witjes, Caroline D. M.
    ten Kate, Fiebo J. W.
    van Aalten, Susanna M.
    Dwarkasing, Roy S.
    Willemssen, Francois E. J. A.
    Verhoef, Cornelis
    de Man, Robert A.
    IJzermans, Jan N. M.
    GUT, 2012, 61 (11) : 1645 - 1646
  • [43] Local and systemic thrombotic complications in cirrhotic patients with hepatocellular carcinoma
    Zanatta, Elisa
    Shalaby, Sarah
    Zanetto, Alberto
    Burra, Patrizia
    Senzolo, Marco
    HEPATOMA RESEARCH, 2024, 10
  • [44] Pilot study of sirolimus in cirrhotic patients with advanced hepatocellular carcinoma
    Decaens, T.
    Luciani, A.
    Itti, E.
    Hulin, A.
    Hurtova, M.
    Laurent, A.
    Cherqui, D.
    Mallat, A.
    Duvoux, C.
    JOURNAL OF HEPATOLOGY, 2008, 48 : S13 - S13
  • [45] Characterization of the immune infiltrates in Cirrhotic livers of HepatoCellular Carcinoma Patients
    Muhammad, Ramzan
    Sturm, Nathalie
    Arafah, Karim
    Avers, Philippe
    Jouvin-Marche, Evelyne
    Zarski, Jean-Pierre
    Leroy, Vincent
    Berger, Francois
    Bulet, Philippe
    Marche, Patrice N.
    BULLETIN DU CANCER, 2011, 98 : S48 - S49
  • [46] Cryosurgery after chemoembolization for hepatocellular carcinoma in cirrhotic patients.
    Kang, KJ
    Morse, MM
    Suhocki, PV
    Clavien, PA
    HEPATOLOGY, 2000, 32 (04) : 617A - 617A
  • [47] Serum level of hepcidin in cirrhotic patients as a marker for hepatocellular carcinoma
    Mohiedeen, Khaled Mahmoud
    Tahoon, Mona Moustafa
    Hanna, Christina Samir Sadek
    Aziz, Mohamed Adel Abdel
    EGYPTIAN LIVER JOURNAL, 2024, 14 (01)
  • [48] Dietary components modulate the risk of hepatocellular carcinoma in cirrhotic patients
    Rizk, Maud
    Guilloteau, Adrien
    Mouillot, Thomas
    Thiefin, Gerard
    Bronowicki, Jean-Pierre
    Richou, Carine
    Doffoel, Michel
    Assaf, Mona Diab
    Hillon, Patrick
    Cottet, Vanessa
    NUTRITION RESEARCH, 2019, 61 : 82 - 94
  • [49] Hepatic resection for hepatocellular carcinoma in cirrhotic patients with portal hypertension
    Zakaria, Hazem M.
    Gad, Emad H.
    Nada, Ali
    Abdelaleem, Anwar A.
    Maher, Doha
    Samea, Mohammad E. Abdel
    Sabry, Alyaa
    SURGICAL PRACTICE, 2016, 20 (04) : 149 - 156
  • [50] Current concepts in hepatic resection for hepatocellular carcinoma in cirrhotic patients
    Cucchetti, Alessandro
    Cescon, Matteo
    Trevisani, Franco
    Pinna, Antonio Daniele
    WORLD JOURNAL OF GASTROENTEROLOGY, 2012, 18 (44) : 6398 - 6408